STRATA Skin Sciences (NASDAQ:SSKN) Earns Buy Rating from Analysts at Maxim Group

Maxim Group assumed coverage on shares of STRATA Skin Sciences (NASDAQ:SSKN) in a research note released on Thursday, Marketbeat.com reports. The brokerage issued a buy rating and a $6.00 price target on the medical device company’s stock.

STRATA Skin Sciences Price Performance

Shares of NASDAQ SSKN opened at $2.64 on Thursday. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62. The firm has a market cap of $11.01 million, a PE ratio of -0.99 and a beta of 1.33. The company has a fifty day moving average price of $2.87 and a 200 day moving average price of $2.97. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $6.00.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.